Trang chủMartial ArtsInam Butt almost certain to receive only 2-month ban: ITA accepts eye treatment defense

Inam Butt almost certain to receive only 2-month ban: ITA accepts eye treatment defense

Câu trả lời trọng tâm: ITA chấp nhận lời giải thích của vận động viên đấu vật Pakistan Inam Butt rằng chất cấm trong mẫu thử đến từ thuốc điều trị mắt, không phải chất tăng cường thành tích. Anh dự kiến bị cấm thi đấu 2 tháng (tính từ tháng 4/2026) và bị tước huy chương bạc Asian Beach Games, nhưng vẫn đủ điều kiện dự Asian Games. Sự kiện chính: Inam Butt, cựu vô địch beach wrestling thế giới người Pakistan, dương tính với chất cấm tại Asian Beach Games tháng 4/2026. ITA xác nhận thuốc điều trị mắt không nhằm nâng cao thành tích; lỗi là không xin TUE kịp thời. Mức án dự kiến: cấm thi đấu 2 tháng, tính ngược từ tháng 4; huy chương bạc bị tước. Butt từ chức Tổng thư ký Liên đoàn Đấu vật Pakistan và Chủ tịch Ủy ban Vận động viên POA. Quyết định chính thức dự kiến trong vòng 1 tuần; Butt vẫn đủ điều kiện dự Asian Games tại Nhật Bản. Nguồn: Tổng hợp từ phân tích vụ việc, tháng 8/2026 | Cross-checked: VuaBong.vn Hỏi đáp liên quan: Q: Tại sao Inam Butt chỉ bị cấm 2 tháng dù dương tính với chất cấm? A: ITA chấp nhận thuốc điều trị mắt không tăng cường thành tích và xác định lỗi do không xin TUE kịp thời, thuộc khung giảm nhẹ. Q: Inam Butt có mất huy chương bạc Asian Beach Games không? A: Có, theo nguyên tắc trách nhiệm nghiêm ngặt, huy chương bị tước bất kể mục đích điều trị. Q: Vận động viên có còn dự Asian Games 2026 tại Nhật Bản không? A: Có, nếu án phạt 2 tháng được áp dụng hồi tố từ tháng 4, án đã hết hiệu lực trước khi Asian Games khởi tranh.

At around 10 a.m. Geneva time, the ITA meeting room had no cameras. No stadium, no flags, no roar of the crowd. But the decision to be made there this week will determine whether a former world champion can step onto the wrestling mat at the Asian Games. Inam Butt, Pakistan's beach wrestling world champion, has waited for his explanation to be accepted. The International Testing Agency (ITA) confirmed the substance he used was for eye treatment, not performance enhancement. But the door of hope only opened partway: a crack in procedure left him facing a sanction. The crack in Buriram's data was not an error but a door – this time, that door leads into an anti-doping hearing room. Inam Butt is not an unfamiliar name to Asian wrestling fans. He once stood on the top podium at the Beach Wrestling World Championships – a young discipline under United World Wrestling (UWW), where wrestlers grapple on sand instead of a mat. The title lacks the historical depth of an Olympic or classical freestyle world title, but it remains a significant milestone for an athlete from a nation with a long wrestling tradition. Last April, Butt won silver at the Asian Beach Games. The joy was short-lived. His doping test came back positive for a substance found in eye medication. He did not deny using it, but insisted it was a legitimate medical need. What complicates the story: he failed to obtain a Therapeutic Use Exemption (TUE) in time. Just months earlier, he was secretary-general of the Pakistan Wrestling Federation (PWF) and chairman of the Athletes' Commission at the Pakistan Olympic Association (POA). A man holding management roles, yet he let his own paperwork slip. The ITA – the independent body that handles anti-doping cases on behalf of international federations – reviewed Butt's file. Multiple sources say the agency accepted the explanation that the drug was for eye treatment, not for enhancing performance. This is the key point. Under WADA rules, distinguishing between a prohibited substance that enhances performance and legitimate therapeutic medication determines the severity of the sanction. If the ITA determines the substance provided no competitive advantage, the case moves toward mitigation. Sources say the ITA is expected to issue a formal decision within a week. The proposed penalty: a roughly two-month suspension, backdated to April – the time of the Asian Beach Games. That means the ban is nearly served. The silver medal from April is almost certain to be stripped. But more importantly: Butt remains eligible for the upcoming Asian Games in Japan, where he serves as national team coach. One detail in the reporting needs careful scrutiny. The article states Butt failed to obtain a TUE in time, yet also mentions the ITA granted permission for the medication for a one-year period. These two facts can be reconciled only if the TUE was granted retroactively, or covered a different treatment window. In WADA practice, retroactive TUEs are accepted only in exceptional circumstances: medical emergencies, insufficient time to complete paperwork, or other objective reasons. That the ITA accepted – even at the level of leaked information – suggests the panel weighed the medical evidence in good faith. In the history of TUE-related cases, the ITA and anti-doping bodies usually apply leniency when an athlete demonstrates a clear therapeutic origin. However, the degree of leniency depends on whether the substance falls under the specified substances list. Specified substances – often common medications – are easier to treat leniently than prohibited substances. Data from similar cases shows that athletes committing procedural errors with accepted therapeutic medication typically receive bans of two to six months, rather than two years for intentional use. This explains why Butt's expected penalty – about two months – sits within professional expectations, though the information is not yet officially confirmed. The body never negotiates; it silently signs the verdict first. What matters is not the two-month ban – but the word 'doping' in a champion's record, however mitigated. Under anti-doping rules, strict liability does not care about intent. Athletes are responsible for every substance entering their bodies, whether they knew it or not. The ITA's recognition of the drug's therapeutic nature helps Butt avoid a long ban, but it cannot erase the fact that his silver medal is forfeited under the rules. The counterintuitive angle is this: the lenient sanction is not the most significant point of this story. More concerning is the concentration of Butt's roles – athlete, national team coach, federation secretary-general, and POA athletes' commission chairman. One person holding so many roles in a small federation system means nobody independently reviews his TUE paperwork. He voluntarily stepped down from two management positions when the case became public – a correct move in sports ethics – but the action also exposes a structural flaw: smaller federations often place too much responsibility on one individual. Based on my experience watching matches in Thailand and Southeast Asia, I have noticed this role-concentration model is common in countries with limited sports budgets. A coach who is also a manager, an athlete who is also a referee, a secretary-general who is also a national team member. Without separation between competitor, coach, and administrator, compliance procedures – such as applying for a TUE on time – become the first victim. The open question is not whether Inam Butt's sanction will be heavy or light. It is: who will stand between the athlete and the complex anti-doping process, so that a pair of eyes needing treatment does not become a stain on a competition record? The Pakistan Wrestling Federation – and many other small federations in the region – needs an answer before the next athlete inadvertently crosses the thin line between medical treatment and rule violation. I trust silently stored numbers more than loud promises. Because a TUE is not a free pass; it is a shield athletes must request in advance, before the body begins to cry out. And the two-month penalty – if confirmed – will be a quiet reminder that the anti-doping process can be lenient toward procedural errors, but never forgets the substance that entered the body.
Cầu thủ liên quan